Steven Cohen’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.58M Buy
209,797
+95,791
+84% +$2.8M 0.01% 1871
2026
Q2
$4.13M Buy
+114,006
New +$3.9M ﹤0.01% 1892
2023
Q4
– Sell
-952
Closed -$21.3K – 2257
2023
Q3
$21.3K Buy
+952
New +$21.7K ﹤0.01% 2284
2023
Q2
– Sell
-1,795
Closed -$43.1K – 2254
2023
Q1
$43.1K Buy
+1,795
New +$47.6K ﹤0.01% 1813
2021
Q2
– Sell
-133,522
Closed -$3.16M – 989
2021
Q1
$3.16M Buy
+133,522
New +$3.17M 0.01% 662
2017
Q1
– Sell
-28,000
Closed -$436K – 827
2016
Q4
$436K Buy
+28,000
New +$465K ﹤0.01% 638

Other funds holding COLL

Steven Cohen's COLL Position: Q3 2026 in Review

Steven Cohen increased its Collegium Pharmaceutical (COLL) stake by 84% in Q3 2026, buying an estimated $2.8M and bringing the position to 209,797 shares worth $4.58M. The position accounts for 0.01% of the portfolio, ranked #1871.

Steven Cohen first reported a position in COLL in Q4 2016 and has held it in 6 quarters since. 239 funds tracked by Wall St. Rank hold COLL as of Q3 2026.

  • Steven Cohen held 209,797 shares of Collegium Pharmaceutical worth $4.58M as of Q3 2026.
  • Steven Cohen bought 95,791 Collegium Pharmaceutical shares in Q3 2026, an estimated $2.8M.
  • Collegium Pharmaceutical made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1871 holding.
  • Steven Cohen first reported a position in Collegium Pharmaceutical in Q4 2016 and has held it in 6 quarters since.
  • 239 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.